Results 161 to 170 of about 52,061 (305)
AUTACE is a bifunctional nanoplatform that integrates tumor targeting, immune engagement, and on‐demand KRAS degradation. It targets KRAS/TP53 co‐mutant tumors via TP53‐specific TCRs, elicits antitumor CD8+ T‐cell responses through surface anti‐CD3 antibodies, and uses low‐intensity focused ultrasound (LIFU) to trigger controlled release of the KRAS ...
Luo Li +6 more
wiley +1 more source
PRDM1 expression levels in marginal zone lymphoma and lymphoplasmacytic lymphoma [PDF]
Hassan, Anjum +5 more
core +1 more source
This study identifies GDF15+ TAMs as a cell subset mediating tumor regression after immunotherapy. Macrophage‐intrinsic GDF15 enhances phagocytosis and antigen cross‐presentation to CD8+ T cells through the NF‐κB signaling pathway, thereby inhibiting tumor progression.
Xinyu Zhou +9 more
wiley +1 more source
Splenic B-Cell Lymphoma/Leukemia With Prominent Nucleoli Presenting With Characteristic Peripheral Blood and Bone Marrow Findings. [PDF]
Son K +3 more
europepmc +1 more source
A descriptive review of cardiac tumours in dogs and cats [PDF]
Adissu +103 more
core +1 more source
The versatile CaO2@CuMOF@HAP nanohybrid demonstrates an outstanding MMP9/pH‐triggered release performance for sequential release of osteogenic growth peptide into deep‐seated tumor‐infiltrated bone destruction areas and dual ions into tumor cells, enabling efficient tumor‐associated osteolysis restoration and tumor elimination for more comprehensive ...
Lan Liu +8 more
wiley +1 more source
Aggressive Metastasis With Silent PET/CT: A Lesson From Well-differentiated Splenic Angiosarcoma. [PDF]
Xie M, Zhu H, Liu H, Sun R, Tao W.
europepmc +1 more source
Spontaneous regression of a true splenic cyst: a case report and review of the literature [PDF]
Christos N Stoidis +5 more
core +1 more source

